- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Fetal Free DNA RHD Genotyping Test Kit (PCR Fluorescent Probe) |
| Catalog No. | BTRTK-HMM-0017 |
| Description | Hemolytic disease of the fetus in the newborn (HDFN) is mainly caused by mother-infant ABO blood group system incompatibility, and the probability of HDFN caused by Rh and other blood group system incompatibility is less, but the hemolytic symptom is more serious than that caused by ABO blood group system incompatibility, especially the incidence of the second birth is significantly higher. By detecting free fetal DNA in the peripheral blood of pregnant women, non-invasive prenatal testing of RHD blood groups in fetuses of RHD-negative pregnant women can be performed to provide reference for clinical diagnosis. Prevention of HDFN risk. |
| Applications | This kit is able to detect exons 5, 7, and 10 of the fetal RHD gene during pregnancy, and monitor common D-negative subtypes such as total/partial deletion of exons, 711delC, 712delG, and so on. |
| Sample Type | Whole blood ≥2 mL (12 gestational weeks and above pregnant women, free DNA special blood collection tube, the best 8 hours or less to separate plasma, up to 3 days can be refrigerated transportation). |
| Detection Methods | PCR Fluorescent Probe |
| Estimated Measurement Time | 1 hour and 41 minutes (one-step (10min) operation, amplification products do not need to be transferred for spiking, avoiding laboratory and aerosol contamination). |
| Shelf Life | 18 months |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagenoTech. All rights reserved.
